BD Named to 100 Best Corporate Citizens List by CRO Magazine

FRANKLIN LAKES, N.J., March 11 /PRNewswire-FirstCall/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named to the annual 100 Best Corporate Citizens List by CRO (Corporate Responsibility Officer) Magazine for 2009.

“BD takes seriously our duty to be a good corporate citizen in our communities and the world,” said BD Chairman and Chief Executive Officer Edward J. Ludwig. “At BD, we pursue our corporate purpose of ‘Helping all people live healthy lives’ while balancing the ‘triple bottom line’ of strong economic performance, environmental stewardship and social responsibility. To be included in the CRO listing is a testament to the dedication of BD associates around the world to our Company’s values.”

Based solely on publicly-available data, the 2009 100 Best Corporate Citizens List methodology puts a premium on companies with high levels of public disclosure and transparency. This list has gained national recognition as an indicator of best practices in the area of corporate social responsibility.

CRO Magazine publisher Jay Whitehead said, “In good times, checkbook citizenship can win the day. But in tough times, strong reputations and transparency pack as much punch as a strong balance sheet. In today’s deep recession, human capital and financial capital seek safety–and companies on the 100 Best Corporate Citizens List are today’s safest harbors.”

First published in 2000 by Business Ethics Magazine, the 100 Best Corporate Citizens List published by CRO Magazine is the most-recognized Corporate Responsibility ranking of Russell 1000(R) companies. More information on the 100 Best Corporate Citizens List can be found at www.thecro.com. BD’s Interim 2008 Sustainability Report is available online at http://www.bd.com/sustainability/.

About BD

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.

SOURCE BD